5Gonzales NR,De Pascalis R,Schlom J. Minimizing the immunogenicity of antibodies for clinical application[J].{H}TUMOUR BIOLOGY,2005,(01):31-43.
6Elamm C,Fairweather D,Cooper LT. Pathogenesis and diagnosis of myocarditis[J].{H}HEART,2012,(11):835-840.
7Castellano G,Affuso F,Di Conza P. Myocarditis and dilated cardiomyopathy:possible connections and treatments[J].{H}JOURNAL OF CARDIOVASCULAR MEDICINE,2008,(07):666-671.
8Afanasyeva M,Georgakopoulos D,Rose NR. Autoimmune myocarditis:cellular mediators of cardiac dysfunction[J].{H}Autoimmunity Reviews,2004,(7-8):476-486.
9Staudt A,B?hm M,Knebel F. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy[J].{H}CIRCULATION,2002,(19):2448-2453.
10Cunningham MW. T cell mimicry in inflammatory heart disease[J].{H}Molecular Immunology,2004,(14-15):1121-1127.
5Rezkalla S, Kloner RA, Khatih G, et al. Effect of metoprolol in acute Coxsackievirus B3 murine myocarditis [J]. J Am Coil Cardiol, 1988,12(2) :412-414.
6Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia [J]. N Engl J Med, 2003,348 (17) : 1639-1646.
7Danke NA, Koelle DM, Yee C, et al. Autoreactive T cells in healthy individuals [J]. J fmmunol,2004,172 (10) :5967- 5972.
8Huber SA, Feldman AM, Sartini D. Coxsackievirus B3 induces T regulatory ceils, which inhibit cardiomyopathy in tumor necrosis factor-a transgenic mice [J]. Circ Res. 2006, 99(10) : 1109-1116.
9Huber SA. Coxsackievirus B3-induced myocarditis: infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells [JJ. Virology 2008,378: 292-298.
10Yates J, Rovis F, Mitchell P, et al. The maintenance of human CD4+CD25^- regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol, 2007,19(6) :785-799.
